Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $55000.0.

  • InspireMD's Gains from Investment Securities rose 15000.0% to $55000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $156000.0, marking a year-over-year increase of 185000.0%. This contributed to the annual value of $51000.0 for FY2024, which is 9907.27% down from last year.
  • As of Q3 2025, InspireMD's Gains from Investment Securities stood at $55000.0, which was up 15000.0% from $3000.0 recorded in Q2 2025.
  • InspireMD's 5-year Gains from Investment Securities high stood at $10.0 million for Q2 2022, and its period low was -$25000.0 during Q3 2021.
  • For the 5-year period, InspireMD's Gains from Investment Securities averaged around $1.5 million, with its median value being $22000.0 (2024).
  • Per our database at Business Quant, InspireMD's Gains from Investment Securities tumbled by 60000.0% in 2021 and then surged by 33366666.67% in 2022.
  • InspireMD's Gains from Investment Securities (Quarter) stood at $5000.0 in 2021, then skyrocketed by 39900.0% to $2.0 million in 2022, then skyrocketed by 50.0% to $3.0 million in 2023, then plummeted by 98.57% to $43000.0 in 2024, then grew by 27.91% to $55000.0 in 2025.
  • Its Gains from Investment Securities stands at $55000.0 for Q3 2025, versus $3000.0 for Q2 2025 and $55000.0 for Q1 2025.